Literature DB >> 19784770

Breast cancer expresses functional NMDA receptors.

William G North1, Guohong Gao, Vincent A Memoli, Roy H Pang, Launa Lynch.   

Abstract

We demonstrate here that functional NMDAR1 and NMDAR2 receptors are expressed by Mcf-7 and SKBR3 breast cancer cell lines, and possibly by most or all high-grade breast tumors, and that these receptors are important for the growth of human breast cancer xenografts in mice. RT-PCR demonstrated mRNA for both NMDAR1 and NMDAR2 receptors are expressed in both Mcf-7 and SKBR3 cell lines, and these messages likely have sequences identical to those reported for human mRNAs. Proteins of the expected respective sizes 120 and 170 kD are generated from these mRNAs by the tumor cells. Cell growth was found to be significantly (P < 0.0001) impaired down to 10% of normal growth by the irreversible NMDAR1 antagonists MK-801 and memantine with IC 50s ranging from 600 to >800 microM and from 200 to 300 microM for the two lines. Paradoxically, memantine with a lower binding affinity had the greater influence of the two inhibitors on cell viability. Immunohistochemical examination of high-grade invasive ductal and lobular breast cancer with our polyclonal antibodies against a peptide (-Met-Ser-Ile-Tyr-Ser-Asp-Lys-Ser-Ile-His-) in the extracellular domain of the NMDAR1 receptor gave specific positive staining for the receptor in all 10 cases examined. Positive staining was chiefly concentrated at the membranes of these tumor tissues. No staining with these antibodies was found for normal breast and kidney tissues. When Mcf-7 cells were grown as tumor xenografts in nu/nu mice, the growth of these tumors was completely arrested by daily treatments with MK-801 over 5 days. All of these data point to active NMDAR receptors being expressed by most breast cancers, and having an important influence on their survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784770      PMCID: PMC4747431          DOI: 10.1007/s10549-009-0556-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

Review 1.  International consensus conference. Image-detected breast cancer: state of the art diagnosis and treatment.

Authors: 
Journal:  Breast J       Date:  2002 Mar-Apr       Impact factor: 2.431

2.  Presence of functional NMDA receptors in a human neuroblastoma cell line.

Authors:  W G North; M J Fay; J Du; M Cleary; J D Gallagher; F V McCann
Journal:  Mol Chem Neuropathol       Date:  1997 Jan-Feb

3.  Molecular cloning and characterization of the rat NMDA receptor.

Authors:  K Moriyoshi; M Masu; T Ishii; R Shigemoto; N Mizuno; S Nakanishi
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

4.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.

Authors:  S A Ahmed; R M Gogal; J E Walsh
Journal:  J Immunol Methods       Date:  1994-04-15       Impact factor: 2.303

Review 5.  Gene regulation of vasopressin and vasopressin receptors in cancer.

Authors:  W G North
Journal:  Exp Physiol       Date:  2000-03       Impact factor: 2.969

6.  The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.

Authors:  M E Gilbert
Journal:  Brain Res       Date:  1988-10-25       Impact factor: 3.252

Review 7.  Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

Authors:  S K Sonkusare; C L Kaul; P Ramarao
Journal:  Pharmacol Res       Date:  2005-01       Impact factor: 7.658

8.  Human neurophysins as potential tumor markers for small cell carcinoma of the lung: application of specific radioimmunoassays.

Authors:  W G North; L H Maurer; H Valtin; J F O'Donnell
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

9.  Neuropeptide production by small cell carcinoma: vasopressin and oxytocin as plasma markers of disease.

Authors:  W G North
Journal:  J Clin Endocrinol Metab       Date:  1991-12       Impact factor: 5.958

10.  Vasopressin gene related products are markers of human breast cancer.

Authors:  W G North; S Pai; A Friedmann; X Yu; M Fay; V Memoli
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

View more
  32 in total

1.  Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers.

Authors:  Xiang Jiao; Laura D Wood; Monica Lindman; Sian Jones; Phillip Buckhaults; Kornelia Polyak; Saraswati Sukumar; Hannah Carter; Dewey Kim; Rachel Karchin; Tobias Sjöblom
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

Review 2.  NMDA receptors on the surface of cancer cells: target for chemotherapy?

Authors:  Stephen I Deutsch; Amy H Tang; Jessica A Burket; Andrew D Benson
Journal:  Biomed Pharmacother       Date:  2014-03-27       Impact factor: 6.529

3.  Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.

Authors:  Karen A Oliveira; Tharine Dal-Cim; Flávia G Lopes; Fabiana K Ludka; Cláudia B Nedel; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

Review 4.  α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Authors:  Victor V Uteshev
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells.

Authors:  Maria Beatrice Morelli; Consuelo Amantini; Massimo Nabissi; Giorgio Santoni; Bernhard Wünsch; Dirk Schepmann; Cristina Cimarelli; Maura Pellei; Carlo Santini; Stefano Fontana; Valerio Mammoli; Wilma Quaglia; Alessandro Bonifazi; Mario Giannella; Gianfabio Giorgioni; Alessandro Piergentili; Fabio Del Bello
Journal:  ACS Med Chem Lett       Date:  2019-01-28       Impact factor: 4.345

6.  Roles of N-methyl-D-aspartate receptors and D-amino acids in cancer cell viability.

Authors:  Siqi Du; Yu-Sheng Sung; Michael Wey; Yadi Wang; Nagham Alatrash; Alain Berthod; Frederick M MacDonnell; Daniel W Armstrong
Journal:  Mol Biol Rep       Date:  2020-09-05       Impact factor: 2.316

Review 7.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

8.  Conformational rearrangement of the NMDA receptor amino-terminal domain during activation and allosteric modulation.

Authors:  Vojtech Vyklicky; Cherise Stanley; Chris Habrian; Ehud Y Isacoff
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

9.  NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment.

Authors:  William G North; Guohong Gao; Amy Jensen; Vincent A Memoli; Jinlin Du
Journal:  Clin Pharmacol       Date:  2010-04-01

10.  Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.

Authors:  Kimberly J Briggs; Peppi Koivunen; Shugeng Cao; Keriann M Backus; Benjamin A Olenchock; Hetalben Patel; Qing Zhang; Sabina Signoretti; Gary J Gerfen; Andrea L Richardson; Agnieszka K Witkiewicz; Benjamin F Cravatt; Jon Clardy; William G Kaelin
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.